Recent Finacing
Recent Raise
IO Biotech is a Copenhagen-based clinical-stage biopharmaceutical company developing T‑win platform immuno-oncology therapies that activate T cells against immune-suppressive molecules, with IDO and PD-L1 clinical candidates and melanoma trials.
